Literature DB >> 28082475

Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.

Aritoshi Hattori1, Takeshi Matsunaga1, Kazuya Takamochi1, Shiaki Oh1, Kenji Suzuki1.   

Abstract

Objectives: We aimed to identify the clinicopathological features of loco-regional recurrence after segmentectomy for clinical-T1aN0M0 radiologically invasive non-small-cell lung carcinoma (NSCLC).
Methods: Between 2008 and 2014, 353 patients underwent pulmonary lobectomy or segmentectomy with nodal dissection for clinical-T1aN0M0 radiologically invasive NSCLC showing 0.5 ≤ consolidation tumour ratio (CTR)≤1.0 on thin-section computed tomography (CT). Radiological invasive NSCLC was divided into two groups, i.e. part-solid (0.5 ≤ CTR < 1.0) and pure-solid (CTR = 1.0). Significant prognostic factors for oncological outcomes were evaluated by multivariate analysis.
Results: Lobectomy was performed in 270 (76.5%) patients and segmentectomy in 83 (23.5%). Locoregional recurrence-free survival (LRFS) of clinical-T1a radiologically invasive NSCLC on the whole showed no significant differences between the lobectomy and segmentectomy arms (3-year LRFS, 93.0 vs 90.1%, P  = 0.2725). In contrast, the multivariate analysis revealed that radiologically pure-solid appearance and tumour size were significant predictors of loco-regional recurrence ( P  = 0.0106, 0.0408). Among 212 clinical-T1a radiologically pure-solid NSCLCs, frequency of loco-regional recurrence was high in the segmentectomy arm (20.7%) compared with that of lobectomy arm (8.2%). Furthermore, segmentectomy and larger tumour size were independent significant clinical factors of loco-regional recurrence based on the multivariate analysis ( P  = 0.0292, 0.0402). The 3-year LRFS of the segmentectomy arm was significantly worse than that of the lobectomy arm in the c-T1a disease (82.2 vs 90.6%, P  = 0.0488) provided the tumour showed a pure-solid appearance. Conclusions: Even in cases of small-sized lung carcinoma, segmentectomy should be applied with great caution especially for a radiological pure-solid NSCLC on thin-section CT due to their high incidence of loco-regional recurrence.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Segmentectomy; Locoregional recurrence; Lung carcinoma; Solid tumour

Mesh:

Year:  2017        PMID: 28082475     DOI: 10.1093/ejcts/ezw336

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  18 in total

Review 1.  Whack-a-mole strategy for multifocal ground glass opacities of the lung.

Authors:  Kenji Suzuki
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

2.  Pathologic N1 disease in lung cancer: the segmental and subsegmental lymph nodes.

Authors:  Marc Riquet; Ciprian Pricopi; Giuseppe Mangiameli; Alex Arame; Alain Badia; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 3.  Lymph node dissection during sublobar resection: why, when and how?

Authors:  Pascal-Alexandre Thomas
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  T1a lung carcinoma: the place of segmentectomy in the treatment array.

Authors:  Sameer A Hirji; Scott J Swanson
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

5.  Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.

Authors:  Ke Sun; Aijun You; Bin Wang; Nan Song; Ziwei Wan; Fengying Wu; Wencheng Zhao; Fei Zhou; Wei Li
Journal:  Eur Radiol       Date:  2021-04-15       Impact factor: 5.315

6.  Thoracoscopic segmentectomy for small-sized peripheral lung cancer.

Authors:  Mingyon Mun; Masayuki Nakao; Yosuke Matsuura; Junji Ichinose; Ken Nakagawa; Sakae Okumura
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

7.  Clinical outcome and risk factors for complications after pulmonary segmentectomy by video-assisted thoracoscopic surgery: results of an initial experience.

Authors:  Benoît Bédat; Etienne Abdelnour-Berchtold; Thorsten Krueger; Jean Yannis Perentes; Hans-Beat Ris; Frédéric Triponez; Marc-Joseph Licker; Wolfram Karenovics; Michel Gonzalez
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

8.  Oncologic outcomes of lobectomy vs. segmentectomy in non-small cell lung cancer with clinical T1N0M0 stage: a literature review and meta-analysis.

Authors:  Yu-Zhen Zheng; Wen-Yu Zhai; Jian Zhao; Rui-Xing Luo; Wan-Jie Gu; Shen-Shen Fu; Da Wu; Lian-Xiong Yuan; Wei Jiang; Yasuhiro Tsutani; Hong-Ying Liao; Xiao-Qiang Li
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895

9.  Closing the gap: Contribution of surgical best practices to outcome differences between high- and low-volume centers for lung cancer resection.

Authors:  Mitchell S von Itzstein; Rong Lu; Kemp H Kernstine; Ethan A Halm; Shidan Wang; Yang Xie; David E Gerber
Journal:  Cancer Med       Date:  2020-04-21       Impact factor: 4.452

10.  Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non-small cell lung cancer: A propensity score matching analysis.

Authors:  Yungang Sun; Qiang Zhang; Zhao Wang; Feng Shao
Journal:  Thorac Cancer       Date:  2021-04-01       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.